Literature DB >> 12410072

Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground.

James M Swanson1, Suneel Gupta, Lillie Williams, Dave Agler, Marc Lerner, Sharon Wigal.   

Abstract

OBJECTIVES: To evaluate the pharmacodynamic effects of an experimental (EXP) delivery of methylphenidate (MPH) in children with attention-deficit/hyperactivity disorder and to investigate the situational nature of effects in laboratory classroom and playground settings.
METHOD: A "sipping" study methodology was used to deliver a bolus followed by small but increasing MPH doses as the EXP regimen. A randomized, double-blind crossover design was used to compare the EXP regimen to a thrice-daily (TID) regimen and a placebo (PLA) regimen. Measures of efficacy were obtained from a Motionlogger actigraph to quantify activity and from the Swanson, Kotkin, Agler, M-Flynn, and Pelham (SKAMP) rating scale to quantify two domains of behavior (attention and deportment).
RESULTS: Compared with PLA, both EXP and TID delivery of MPH produced large, significant reductions in activity and inappropriate behavior in the classroom, but the two MPH regimens did not differ in onset or duration of effects across the day. The MPH effects were situationally dependent and were smaller for the playground than for the classroom settings.
CONCLUSIONS: The findings of this "proof of concept" study support the efficacy of a continuous, ascending delivery of MPH. The situational effects of MPH provide support for the theory of selective effects of stimulants, dependent on the demands of the environment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410072     DOI: 10.1097/00004583-200211000-00011

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  24 in total

1.  Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.

Authors:  Bjørn E Ramtvedt; Elisabeth Røinås; Henning S Aabech; Kjetil S Sundet
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-05-09       Impact factor: 2.576

2.  Effects of maternal symptom ratings and other clinical features on short-term treatment response to OROS methylphenidate in children and adolescents with ADHD in a naturalistic clinical setting.

Authors:  Esra Cop Tasgin; Ozgur Oner; Pinar Yurtbasi; Kerim Munir
Journal:  Klinik Psikofarmakol Bulteni       Date:  2016

Review 3.  A Review of the Clinical Utility of Systematic Behavioral Observations in Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  Franziska Minder; Agnieszka Zuberer; Daniel Brandeis; Renate Drechsler
Journal:  Child Psychiatry Hum Dev       Date:  2018-08

Review 4.  Cognitive neuroscience of Attention Deficit Hyperactivity Disorder: current status and working hypotheses.

Authors:  Chandan J Vaidya; Melanie Stollstorff
Journal:  Dev Disabil Res Rev       Date:  2008

5.  Correspondence of parent and teacher reports in medication trials.

Authors:  Stephen V Faraone; Joseph Biederman; Brenda Zimmerman
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-02       Impact factor: 4.785

6.  Comparative efficacy of once-a-day extended-release methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting.

Authors:  Manfred Döpfner; Wolff Dieter Gerber; Tobias Banaschewski; Dieter Breuer; Franz Joseph Freisleder; Gabi Gerber-von Müller; Michael Günter; Frank Hässler; Claudia Ose; Aribert Rothenberger; Klaus Schmeck; Judith Sinzig; Christina Stadler; Henrik Uebel; Gerd Lehmkuhl
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

7.  Development of a Decision Support Model for Screening Attention-deficit Hyperactivity Disorder with Actigraph-based Measurements of Classroom Activity.

Authors:  H J Kam; Y M Shin; S M Cho; S Y Kim; K W Kim; R W Park
Journal:  Appl Clin Inform       Date:  2010-11-10       Impact factor: 2.342

8.  Neuropharmacological effect of methylphenidate on attention network in children with attention deficit hyperactivity disorder during oddball paradigms as assessed using functional near-infrared spectroscopy.

Authors:  Masako Nagashima; Yukifumi Monden; Ippeita Dan; Haruka Dan; Daisuke Tsuzuki; Tsutomu Mizutani; Yasushi Kyutoku; Yuji Gunji; Mariko Y Momoi; Eiju Watanabe; Takanori Yamagata
Journal:  Neurophotonics       Date:  2014-05-28       Impact factor: 3.593

9.  Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day.

Authors:  Frank Lopez; Raul Silva; Linda Pestreich; Rafael Muniz
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder.

Authors:  Philip Shaw; Wendy S Sharp; Meaghan Morrison; Kristen Eckstrand; Deanna K Greenstein; Liv S Clasen; Alan C Evans; Judith L Rapoport
Journal:  Am J Psychiatry       Date:  2008-09-15       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.